Reset filter
Keywords
Endocrinology ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

1131 Search results.
Relevance Rating New first Old first

Eligibility New Onset Diabetes Mellitus After Renal Transplantation NCT01268995

- 9/23/21 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT01268995

Eligibility Metabolic Syndrome NCT00917449

- 5/3/17 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00917449

Eligibility Diabetic Nephropathy NCT00141453

- 9/7/16 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial; ODM derived from: https://clinicaltrials.gov/show/NCT00141453

Eligibility Type 2 Diabetes NCT01792206

- 9/22/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01792206

Eligibility Diabetes NCT01507389

- 9/17/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function; ODM derived from: https://clinicaltrials.gov/show/NCT01507389

Eligibility Diabetes NCT01508806

- 3/15/17 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function; ODM derived from: https://clinicaltrials.gov/show/NCT01508806

Eligibility Metabolic Syndrome NCT02517697

- 5/8/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Oral Nitrite Placebo Controlled Trial for Hypertension and Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT02517697

Eligibility Metabolic Syndrome NCT01705678

- 1/6/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01705678

Eligibility Metabolic Syndrome NCT00937638

- 6/16/18 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00937638

Eligibility Metabolic Syndrome NCT00655902

- 6/15/18 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Copenhagen Obesity Risk Assessment Study; ODM derived from: https://clinicaltrials.gov/show/NCT00655902

Eligibility Metabolic Syndrome NCT00170937

- 10/19/16 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00170937

Eligibility Diabetes NCT00833716

- 3/10/18 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Renal Impairment on the Pharmacokinetics of NN9535; ODM derived from: https://clinicaltrials.gov/show/NCT00833716

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial